Radiopharm Theranostics Limited American Depositary Shares

RADX XNAS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

36M

Short interest (May 15)

0.6%

Borrow Fee

44.80%

↑ 0.8%

Available Shares

70K

↓ 24.4%

Price Chart

Company Overview

Radiopharm Theranostics Ltd is an Australian-based clinical-stage radiotherapeutics company targeting cancer. The company has a pipeline of approximately four licensed platform technologies, with diagnostic and therapeutic applications at both the pre-clinical and clinical stages of development. The company is engaged in research, development, and commercialization of health technologies.

Company Info

Exchange: NASDAQ

CIK: 0001949257

Asset Type: ADRC

Market Data

Market Cap: $35,868,400

Employees: 14

Status: Active

Short Interest

Current Borrow Fee 44.80%

Range: 39.55% - 44.80%

Available Shares 70K

Range: 40K - 70K

Recent Changes

Fee Change: ↑ 3.8%

Available Change: ↓ 16.7%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime